$CRWV

CoreWeave Has $104 Billion of Contracted Revenue and a $59 Billion Market Value

CoreWeave (CRWV) reported Q2 revenue of $2.6B, up 112% YoY, with a $104B revenue backlog, up from $30.1B a year ago. The company raised its 2026 capital spending plan to $35B-$39B and reported a net loss of $626M. Shares rose 19% post-earnings, valuing the company at $59B.

Original reporting
Published Aug 19, 2026, 2:07 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 9:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CoreWeave Has $104 Billion of Contracted Revenue and a $59 Billion Market Value — source image
Decision brief

The 30-second read

$CRWVNeutralHigh
01

Why it matters

The numbers suggest strong demand but also highlight execution risk due to capital intensity and debt servicing.

02

Market read

CoreWeave's results could reshape investor sentiment toward AI infrastructure stocks and influence capital allocation decisions in the sector.

03

What to watch

Regulatory and political resistance to new data‑center construction in key U.S. states may limit capacity expansion.

Relevance 8/10Novelty 8/10Timing: post‑market Wednesday after earnings release

Background

CoreWeave reported Q2 2026 results, revealing a $104B backlog and raising its 2026 capital spend to $35‑$39B.

Company-level read

Ticker impact

$CRWVNeutralHigh confidence
Context

Q2 results disclosed a $104B backlog, 112% revenue growth and updated 2026 guidance, causing a 19% share jump.

Expected impact

Potential short‑term upside if capacity ramps faster; downside risk if debt service pressures earnings.

Evidence & confidence

The disclosed backlog-to‑revenue ratio (56c per $1) suggests a valuation discount, but capital spending and interest expense exceed near‑term operating income.

Market effects

Highlights demand for AI‑cloud capacity, may boost peers like Nvidia and other data‑center providers.

U.S. AI infrastructure sector sees heightened investor interest.

Backlog size underscores global AI compute shortage, could influence overseas AI‑cloud operators.

Counterpoint

The massive debt load and rising interest expense could outweigh backlog benefits, leading to a price correction.

Key entities

  • CoreWeave

    AI cloud provider listed on NASDAQ (CRWV).

  • Meta Platforms

    Customer adding $21B to CoreWeave's backlog.

  • Anthropic

    AI lab signing multi‑year agreement with CoreWeave.

Related articles

$CRWVHighAI 9/10

CoreWeave Signs Hudson River Trading to a Multiyear AI Deal

CoreWeave (CRWV) signed a multiyear, multibillion-dollar AI computing deal with Hudson River Trading. The agreement expands their existing partnership, with HRT gaining access to Nvidia's (NVDA) Vera Rubin chips. CoreWeave aims to diversify from Microsoft (MSFT), with shares up 0.36% intraday.

$CRWVMedAI 8/10

CoreWeave Stock Fell While The Price Of Its Compute Went Up

CoreWeave (CRWV) stock is down 6.1% over the past year, trading at $91. The company expects new contracts to have 5-10% higher contribution margins. Revenue was $7.6B over the past year. Adjusted operating income was $128M in Q2, with capital spending guided to $35B-$39B for 2026. Management raised full-year 2026 revenue guidance to $12.4B-$13.2B.

MedAI 8/10

Hudson River Trading taps CoreWeave for research platform

Hudson River Trading (HRT) has partnered with CoreWeave to use its AI cloud for research, utilizing Nvidia's NVL72 and HGX B200 systems. The multi-year agreement is valued in the billions, according to sources. HRT aims to enhance its AI-powered trading research and model development. CoreWeave's cloud will support HRT's growing compute needs, similar to other quantitative trading firms like IMC and Jane Street.

$CRWVMed

CoreWeave Drops 12%, but Truist Still Sees 66% Upside

CoreWeave Inc. (CRWV) shares dropped 12.1% to $93.17 on Tuesday. Truist analyst Arvind Ramnani maintained a Buy rating with a $155 price target, citing potential margin improvements and growth in managed inference services. The company faces risks including high debt and insider selling.